Serum adiponectin is a potential biomarker for metabolic syndrome in peri-and postmenopausal women
Sign Up to like & getrecommendations! Published in 2020 at "Gynecological Endocrinology"
DOI: 10.1080/09513590.2020.1742688
Abstract: Abstract Metabolic syndrome (MetS) increases its prevalence during menopausal period and there is no appropriate marker for screening before the cardiovascular damage begun. This study aims to find the diagnostic accuracy and the appropriate cutoff… read more here.
Keywords: biomarker; peri postmenopausal; serum adiponectin; metabolic syndrome ... See more keywords